Terbinafine/betamethasone acetate

Terbinafine/betamethasone acetate, sold under the brand name Duotic is a veterinary medication used for the treatment of otitis externa (ear infections) in dogs.[1] It is a fixed dose combination of terbinafine, an antifungal; and betamethasone acetate, a glucocorticosteroid anti-inflammatory.[1][2]

Terbinafine/betamethasone acetate
Combination of
TerbinafineAntifungal
Betamethasone acetateGlucocorticosteroid
Clinical data
Trade namesDuotic
License data
Routes of
administration
Ear drop
ATCvet code
Legal status
Legal status

The combination is the first FDA-approved animal drug intended to treat yeast-only otitis externa in dogs.[2] It is also the first otic drug intended to treat otitis externa that does not contain an antibiotic.[2]

Terbinafine/betamethasone acetate was approved for medical use in the United States in March 2024.[1][2]

Society and culture

edit

In October 2024, the Committee for Veterinary Medicinal Products of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the veterinary medicinal product Duotic, Ear gel, intended for dogs.[3] The applicant for this veterinary medicinal product is Dechra Regulatory B.V.[3]

Veterinary uses

edit

Terbinafine/betamethasone acetate is indicated for the treatment of otitis externa in dogs, associated with susceptible strains of yeast (Malassezia pachydermatis).[1][2]

References

edit
  1. ^ a b c d e https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/15165 Archived 20 March 2024 at the Wayback Machine   This article incorporates text from this source, which is in the public domain.
  2. ^ a b c d e "FDA Approves Treatment for Yeast Ear Infections in Dogs". U.S. Food and Drug Administration (FDA). 15 March 2024. Archived from the original on 20 March 2024. Retrieved 20 March 2024.   This article incorporates text from this source, which is in the public domain.
  3. ^ a b "Duotic EPAR". European Medicines Agency (EMA). 10 October 2024. Retrieved 12 October 2024. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.